221
Views
32
CrossRef citations to date
0
Altmetric
Original Articles

Serum miR-210 and miR-155 expression levels as novel biomarkers for rheumatoid arthritis diagnosis

, ORCID Icon, ORCID Icon, , , & show all
Pages 209-213 | Received 24 Jan 2017, Accepted 06 Jun 2017, Published online: 07 Aug 2017

References

  • Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358:903–911.10.1016/S0140-6736(01)06075-5
  • Goekoop-Ruiterman YP, De Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381–3390.10.1002/(ISSN)1529-0131
  • Breedveld FC, Weisman MH, Kavanaugh AF, et al. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26–37.10.1002/(ISSN)1529-0131
  • Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012;51:v3–v11.10.1093/rheumatology/kes113
  • Sun B, Liu X, Gao Y, et al. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Br J Biomed Sci. 2016;73(4):152–157.
  • Yadegaria ZS, Akramia H, Hosseinib SY, et al. miR-146a gene polymorphism and susceptibility to gastric cancer. Br J Biomed Sci. 2016;73(4):201–203.
  • Ren X, Shen Y, Zheng S, et al. miR-21 predicts poor prognosis in patients with Osteosarcoma. Br J Biomed Sci. 2016;73(4):158–162.
  • Liu C, Xing M, Wang L, et al. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Biomed Sci.. 2017;74(2):90–94.
  • Brooks WH, Le Dantec C, Pers JO, et al. Epigenetics and autoimmunity. J Autoimmun. 2010;34:J207–J219.10.1016/j.jaut.2009.12.006
  • Furer V, Greenberg JD, Attur M, et al. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol. 2010;136:1–15.10.1016/j.clim.2010.02.005
  • Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Nat Acad Sci. 2008;105:10513–10518.10.1073/pnas.0804549105
  • D’Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31:2765–2773.10.1093/eurheartj/ehq167
  • Ji F, Yang B, Peng X, et al. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat. 2011;18:e242–e251.10.1111/j.1365-2893.2011.01443.x
  • Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001–1009.10.1002/art.23386
  • Pauley KM, Satoh M, Chan AL, et al. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Therapy. 2008;10(4):R101.10.1186/ar2493
  • Nakamachi Y, Kawano S, Takenokuchi M, et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2009;60(5):1294–1304.
  • Niederer F, Trenkmann M, Ospelt C, et al. Down-regulation of microRNA-34a∗ in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance. Arthritis Rheuma. 2012;64(6):1771–1779.
  • Dong L, Wang X, Tan J, et al. Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J Cell Mol Med. 2014;18:2213–2224.10.1111/jcmm.2014.18.issue-11
  • Lin J, Huo R, Xiao L, et al. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014;66:49–59.10.1002/(ISSN)2326-5205
  • Xu T, Huang C, Chen Z, et al. MicroRNA-323-3p: a new biomarker and potential therapeutic target for rheumatoid arthritis. Rheumatol Int. 2014;34:721–722.10.1007/s00296-013-2767-3
  • Olarerin-George AO, Anton L, Hwang YC, et al. A functional genomics screen for microRNA regulators of NF-kappaB signaling. BMC Biol. 2013;11:19–34.10.1186/1741-7007-11-19
  • Zhang D, Cao X, Li J, et al. MiR-210 inhibits NF-κB signaling pathway by targeting DR6 in Osteoarthritis. Sci Rep. 2015;5:12775–12782.10.1038/srep12775
  • Kurowska-Stolarska M, Alivernini S, Ballantine LE, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Nat Acad Sci. 2011;108:11193–11198.10.1073/pnas.1019536108
  • Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.10.1002/(ISSN)1529-0131
  • Arnett FC, Edworthy SM, Bloch DA, et al. Modified disease activity scores thatinclude twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–48.
  • Westergren A. Studies of the suspension stability of the blood in pulmonary tuberculosis. Acta Med Scand. 1921;54:247–282.
  • Everitt BS. Contrasts and custom hypothesis. The Cambridge dictionary of statistics. 2nd ed. Cambridge: CUP; 2002;13:329–338. ISBN 0-521-81099-X.
  • Mody GM. Reflections on rheumatoid arthritis in selected sub-Saharan African countries. East Afr Med J. 2009;86:201–203.
  • Cobb BS, Hertweck A, Smith J, et al. A role for Dicer in immune regulation. J Exp Med. 2006;203:2519–2527.10.1084/jem.20061692
  • Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129:147–161.10.1016/j.cell.2007.03.008
  • Yamasaki K, Nakasa T, Miyaki S, et al. Angiogenic microRNA-210 is present in cells surrounding osteonecrosis. J Orthop Res. 2012;30:1263–1270.10.1002/jor.22079
  • Zhang Y, Fei M, Xue G, et al. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med. 2012;16:249–259.10.1111/jcmm.2012.16.issue-2
  • Li X, Tian F, Wang F. Rheumatoid arthritis-associated MicroRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs. Int J Mol Sci. 2013;14:23910–23921.10.3390/ijms141223910
  • Qi J, Qiao Y, Wang P, et al. microRNA-210 negatively regulates LPS-induced production of proinflammatory cytokines by targeting NF-κB1 in murine macrophages. FEBS Lett. 2012;586(8):1201–1207.10.1016/j.febslet.2012.03.011
  • O’Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat Rev Immunol. 2011;11:163–175.10.1038/nri2957
  • Samaan S, Khella HW, Girgis A, et al. miR-210 is a prognostic marker in clear cell renal cell carcinoma. J Mol Diagn. 2015;17:136–144.10.1016/j.jmoldx.2014.10.005
  • Faraonia I, Antonettib FR, Cardonea J, et al. miR-155 gene: a typical multifunctional. microRNA. Biochem Biophys Acta. 2009;1792(6): 497–505.
  • Luzi E, Marini F, Sala SC, et al. Osteogenic differentiation of human adipose tissue derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Mineral Res. 2008;23(2):287–295.
  • Elmesmari A, Fraser AR, Wood C, et al. MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis. Rheumatology. 2016;55(11):2056–2065.10.1093/rheumatology/kew272

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.